中文名称: 齐多呋定 促销
英文名称: Zidovudine
CAS No: 30516-87-1
分子式: C10H13N5O4
分子量: 267.24
Z10029 齐多呋定 ≥98% (psaitong)
包装规格:
5g 25g 100g in glass bottle
溶解性:
溶于DMSO(≥ 100 mg/mL)
产品描述:

基本信息

产品编号:Z10029

产品名称:Zidovudine

CAS:

30516-87-1

 

储存条件

粉末

2-8℃

四年

 

 

分子式:

C10H13N5O4

溶于液体

-80℃

两年

分子量

267.24

-20℃

一个月

化学名: 

1-((2R,4S,5S)-4-AZIDO-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE

 

Solubility (25°C)

 

体外

DMSO

53mg/mL (198.32mM)

Ethanol

53mg/mL warmed with 50ºC water bath (198.32mM)

Water

26mg/mL warmed with 50ºC water bath (97.29mM)

体内

现配现用

 

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

3.7420mL

18.7098mL

37.4195mL

5mM

0.7484mL

3.7420mL

7.4839mL

10mM

0.3742mL

1.8710mL

3.7420mL

50mM

0.0748mL

0.3742mL

0.7484mL

 

生物活性

产品描述

一种核苷逆转录酶抑制剂,有潜力用于 HIV 感染的研究。Zidovudine 增强 CRISPR/Cas9调节的编辑频率。

靶点/IC50

Reverse transcriptase

 

体外研究

Zidovudine inhibits SVG, Primary human fetal astrocytes (PFA), peripheral blood mononuclear cells (PBMC), and monocytederived macrophages (MDM) with EC50 of 17, 1311, 8, and 5nM, respectively. Zidovudine inhibits SVG, PFA, PBMC, and MDM with EC90 of 0.205μM, 44.157μM, 0.481μM, and 0.219μM, respectively. Genome editing via CRISPR/Cas9 has become an efficient and reliable way to make precise, targeted changes to the genome of living cells. CXCR4 is a co-receptor for the human immunodeficiency virus type 1 (HIV-1) infection and has been considered as an important therapeutic target for AIDS. CXCR4 mediates viral entry into human CD4+ cells by binding to envelope protein, gp120. Human CXCR4 gene is efficiently disrupted by CRISPR/Cas9-mediated genome editing, leading to HIV-1 resistance of human primary CD4+ T cells.The Cas9-mediated ablation of CXCR4 demonstrated high specificity and negligible off-target effects without affecting celldivision and propagation.

 

体内研究

ntravitrous injection of the NRTIs Lamivudine (3TC), Zidovudine (AZT), or Abacavir (ABC) suppresses the laser-induced choroidal neovascularization (CNV) in wild-type mice compared to PBS vehicle. The mean level of VEGF-A in the RPE/choroid, which peaks on day 3 after laser injury, is significantly reduced in 3TC-, AZT- and ABC-treated eyes compared with control eyes in wild-type mice, but not inP2rx7-/- mice.

特征

 

 

推荐实验方法(仅供参考)

细胞实验:

 

Cell Assay

Assays are performed in all cell types in the presence of titrating concentrations of ARV. 5,000 SVG, 2,500 PFA, 200,000 PBMC,or 50,000 MDM cells/well are seeded into triplicate wells of 96-well plates. Twenty-four hours later, the culture medium is removed and replaced with medium containing the ARV or DMSO (0.5% vol/vol), and equivalent TCID50 infectious units of luciferase reporter virus are added to the cells. After a 16h incubation at 37°C, the initial viral inoculum is removed and replaced with culture medium containing the same antiretroviral drug (ARV) or DMSO (0.5% vol/vol) concentrations. At 72h post infection, the medium is aspirated, the cells are lysed and HIV-1 infection measured using the Luciferase Assay System. Luminescence is measured using a FLUOStar Optima microplate reader. Inhibition curves and the 50% (EC50) and 90% (EC90) effective concentrations are determined by nonlinear regression analysis, using GraphPad Prism software

 

动物实验:

 

Animal Administration

Mice C57BL/6J (wild-type) and P2rx7-/- mice are used. The Nlrp3-/- mice are used. The NRTIs 3TC, AZT, and ABC or the P2X7antagonist A438079 hydrochloride are dissolved in PBS. For CNV, each group of mice is injected once with 1μL of NRTIs (3TC, 125ng/μL; ABC, 183ng/μL; AZT, 146ng/μL), 1μL of A438079 hydrochloride (3, 30, or 300ng/μL), or the same volume of vehicle (PBS) into the vitreous humor using a 33-gauge needle immediately after laser injury. Another group of mice is injected with 3TC (125ng) in combination with an anti-mouse VEGF polyclonal antibody (10ng). Goat whole IgG (10ng) is used as a biological control for the anti-mouse VEGF antibody.

保存条件:
2-8℃
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):